Prenate DHA

Avion Pharmaceuticals Prenate DHA -

Product Type

Packaging Size

0.0 Not Present
30.0 Softgel(s)

Serving Size

1.0 Softgel(s)

Ingredients

vitamin c90.0mg
vitamin b626.0mg
vitamin b1213.0mcg
vitamin d3220.0iu
vitamin e10.0iu
docosahexaenoic acid300.0mg
calcium145.0mg
magnesium50.0mg
iron28.0mg
as 11 mg quatrefolic1.1mg
folate1.0mg
folic acid400.0mcg

Description

Rev. 021412 HOW SUPPLIED: Unit-dose packs of 30 softgels. (75854-302-30). The listed product number is not a National Drug Code, but has instead merely been formatted to comply with standard industry practice for pharmacy and insurance computer systems. Rx Only

Formulation

With Quatrefolic(R) INDICATIONS: PRENATE DHA(R) is a multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers. PRENATE DHA(R) can also be beneficial in improving the nutritional status of women prior to conception. Rx prenatal vitamin & DHA PRENATE DHA(R) contains fish oil and soy.

Precautions

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. PRENATE DHA(R) contains fish oil and soy. Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those know to have an inherited or acquired predisposition to bleeding. WARNING: Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those know to have an inherited or acquired predisposition to bleeding. PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloglastic anemias where Vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. CONTRAINDICATIONS: PRENATE DHA(R) is contraindicated in patients with a known hypersensitivity to any of the ingredients. ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Related Products